David Balgoma
- Application of ’omics technologies to biomarker discovery in inflammatory lung diseasesBy Craig E. Wheelock, Victoria M. Goss, David Balgoma, Ben Nicholas, Joost Brandsma, Paul J. Skipp, Stuart Snowden, Dominic Burg, Arnaldo D'Amico, Ildiko Horvath, Amphun Chaiboonchoe, Hassan Ahmed, Stéphane Ballereau, Christos Rossios, Kian Fan Chung, Paolo Montuschi, Stephen J. Fowler, Ian M. Adcock, Anthony D. Postle, Sven-Erik Dahlén, Anthony Rowe, Peter J. Sterk, Charles Auffray, Ratko Djukanović and the U-BIOPRED Study GroupCraig E. Wheelock1Dept of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, Stockholm2Centre for Allergy Research, Karolinska Institutet, StockholmVictoria M. Goss3Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, SouthamptonDavid Balgoma1Dept of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, Stockholm2Centre for Allergy Research, Karolinska Institutet, StockholmBen Nicholas3Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, SouthamptonJoost Brandsma3Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, SouthamptonPaul J. Skipp4Centre for Biological Sciences, University of Southampton Faculty of Natural and Environmental Sciences and Centre for Proteomic Research, SouthamptonStuart Snowden1Dept of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, Stockholm2Centre for Allergy Research, Karolinska Institutet, StockholmDominic Burg3Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, Southampton4Centre for Biological Sciences, University of Southampton Faculty of Natural and Environmental Sciences and Centre for Proteomic Research, SouthamptonArnaldo D'Amico5Dept of Electronic Engineering, University of Rome "Tor Vergata", RomeIldiko Horvath6Dept of Pulmonology, Semmelweis University, Budapest, HungaryAmphun Chaiboonchoe7CNRS Institute of Biological Sciences, European Institute for Systems Biology and Medicine, Claude Bernard University, Lyon, FranceHassan Ahmed7CNRS Institute of Biological Sciences, European Institute for Systems Biology and Medicine, Claude Bernard University, Lyon, FranceStéphane Ballereau7CNRS Institute of Biological Sciences, European Institute for Systems Biology and Medicine, Claude Bernard University, Lyon, FranceChristos Rossios8Airways Disease, National Heart and Lung Institute, Imperial College London, LondonKian Fan Chung8Airways Disease, National Heart and Lung Institute, Imperial College London, LondonPaolo Montuschi9Dept of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Rome, ItalyStephen J. Fowler10University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Respiratory Research Group, Education and Research Centre, Wythenshawe Hospital, ManchesterIan M. Adcock8Airways Disease, National Heart and Lung Institute, Imperial College London, LondonAnthony D. Postle3Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, SouthamptonSven-Erik Dahlén2Centre for Allergy Research, Karolinska Institutet, Stockholm11Unit for Experimental Asthma and Allergy Research, Karolinska Institutet, Stockholm, SwedenAnthony Rowe12Janssen Research and Development Ltd, High Wycombe, UKPeter J. Sterk13Dept of Respiratory Medicine, Academic Medical Center University of Amsterdam, Amsterdam, The NetherlandsCharles Auffray7CNRS Institute of Biological Sciences, European Institute for Systems Biology and Medicine, Claude Bernard University, Lyon, FranceRatko Djukanović3Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, Southampton
- Monitoring PGD2 production in airway diseaseBy Johan Larsson, David Balgoma, Ingrid Delin, Theo Gülen, Gunnar Nilsson, Hans Hägglund, Kameran Daham, John Lawson, Garret FitzGerald, Barbro Dahlén, Craig Wheelock and Sven-Erik DahlénJohan LarssonDavid BalgomaIngrid Delin3The National Institute of Environmental Medicine, Division of Physiology, Karolinska Institutet, Stockholm, SwedenTheo GülenGunnar Nilsson4Department of Clinical Immunology and Allergy, Karolinska University Hospital, Karolinska Institutet, Stockholm, SwedenHans Hägglund5Department of Haematology, Karolinska University Hospital, Karolinska Institutet, Stockholm, SwedenKameran Daham1Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Karolinska Institutet, Stockholm, SwedenJohn Lawson6The Institute for Translational Medicine and Therapeutics, School of Medicine, University of Pennsylvania, Philadelphia, United StatesGarret FitzGerald6The Institute for Translational Medicine and Therapeutics, School of Medicine, University of Pennsylvania, Philadelphia, United StatesBarbro Dahlén1Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Karolinska Institutet, Stockholm, SwedenCraig Wheelock2Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry 2, Karolinska Institutet, Stockholm, Sweden
- Development of mass spectrometry approaches to quantifying lipid mediators in airway diseaseBy David Balgoma, Susanna L. Lundström, Anders Eklund, Johan Grunewald and Craig E. WheelockDavid Balgoma1Department of Medical Biochemistry and Biophysics, Division of Chemistry 2, Karolinska Institutet, Stockholm, SwedenSusanna L. Lundström1Department of Medical Biochemistry and Biophysics, Division of Chemistry 2, Karolinska Institutet, Stockholm, SwedenAnders Eklund2Division of Respiratory Medicine, Department of Medicine, Karolinska Institutet, Stockholm, SwedenJohan Grunewald2Division of Respiratory Medicine, Department of Medicine, Karolinska Institutet, Stockholm, SwedenCraig E. Wheelock1Department of Medical Biochemistry and Biophysics, Division of Chemistry 2, Karolinska Institutet, Stockholm, Sweden
- Gender differences in 5- and 12/15-lipoxygenases products in bronchoalveolar lavage fluid from healthy never-smokers, smoker and COPD patientsBy David Balgoma, Magnus Schöld, Johan Grunewald, Anders Eklund, Åsa Wheelock and Craig WheelockDavid Balgoma1Division of Physiological Chemistry II, MBB, Karolinska Institute, Stockholm, SwedenMagnus Schöld2Respiratory Medicine Unit, Department of Medicine, Karolinska Hospital, Stockholm, SwedenJohan Grunewald2Respiratory Medicine Unit, Department of Medicine, Karolinska Hospital, Stockholm, SwedenAnders Eklund2Respiratory Medicine Unit, Department of Medicine, Karolinska Hospital, Stockholm, SwedenÅsa Wheelock2Respiratory Medicine Unit, Department of Medicine, Karolinska Hospital, Stockholm, SwedenCraig Wheelock1Division of Physiological Chemistry II, MBB, Karolinska Institute, Stockholm, Sweden
- Application of a new mass-spectrometric platform for determination of lipid mediators in urine reveals increased oxidative stress during allergen bronchoprovocation of subjects with atopic asthmaBy David Balgoma, Kameran Daham, Johan Larsson, Agneta Lindeberg, Barbro Dahlén, Joshua Rokach, Craig Wheelock and Sven-Erik DahlénDavid Balgoma1Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, SwedenKameran Daham3Clinical Asthma Research, Karolinska Hospital, Stockholm, SwedenJohan Larsson3Clinical Asthma Research, Karolinska Hospital, Stockholm, SwedenAgneta Lindeberg3Clinical Asthma Research, Karolinska Hospital, Stockholm, SwedenBarbro Dahlén3Clinical Asthma Research, Karolinska Hospital, Stockholm, SwedenJoshua Rokach4Chemistry Department, Florida Institute of Technology, Melbourne, FL, United StatesCraig Wheelock1Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, SwedenSven-Erik Dahlén2Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
- Lipid mediator levels evidence gender-specific increases in bronchoalveolar lavage fluid of COPD patients relative to healthy smokersBy Craig Wheelock, David Balgoma, Johan Grunewald, Anders Eklund, Magnus Skold and Asa WheelockCraig Wheelock1Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, SwedenDavid Balgoma1Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, SwedenJohan Grunewald2Medicine, Karolinska Institute, Stockholm, SwedenAnders Eklund2Medicine, Karolinska Institute, Stockholm, SwedenMagnus Skold2Medicine, Karolinska Institute, Stockholm, SwedenAsa Wheelock2Medicine, Karolinska Institute, Stockholm, Sweden
- Application of ‘omics technologies to biomarker discovery in inflammatory lung diseasesBy Craig E. Wheelock, Victoria M. Goss, David Balgoma, Ben Nicholas, Joost Brandsma, Paul J. Skipp, Stuart Snowden, Arnaldo D'Amico, Ildiko Horvath, Amphun Chaiboonchoe, Hassan Ahmed, Stéphane Ballereau, Christos Rossios, Kian Fan Chung, Paolo Montuschi, Stephen J. Fowler, Ian M. Adcock, Anthony D. Postle, Sven-Erik Dahlén, Anthony Rowe, Peter J. Sterk, Charles Auffray, Ratko Djukanović and the U-BIOPRED Study GroupArticle | Published in 2012 in European Respiratory JournalCraig E. Wheelock*Dept of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, Stockholm, Sweden#Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden;Victoria M. Goss¶Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, Southampton, United Kingdom;David Balgoma*Dept of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, Stockholm, Sweden#Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden;Ben Nicholas¶Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, Southampton, United Kingdom;Joost Brandsma¶Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, Southampton, United Kingdom;Paul J. Skipp+Centre for Biological Sciences, University of Southampton Faculty of Natural and Environmental Sciences and Centre for Proteomic Research, Southampton, United Kingdom;Stuart Snowden*Dept of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, Stockholm, Sweden#Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden;Arnaldo D'Amico§Dept of Electronic Engineering, University of Rome "Tor Vergata", Rome, Italy;Ildiko HorvathfDept of Pulmonology, Semmelweis University, Budapest Dios arok 1/C, H-1125, Hungary;Amphun Chaiboonchoe**CNRS Institute of Biological Sciences, European Institute for Systems Biology & Medicine, Claude Bernard University, Lyon, France;Hassan Ahmed**CNRS Institute of Biological Sciences, European Institute for Systems Biology & Medicine, Claude Bernard University, Lyon, France;Stéphane Ballereau**CNRS Institute of Biological Sciences, European Institute for Systems Biology & Medicine, Claude Bernard University, Lyon, France;Christos Rossios##Airways Disease, National Heart & Lung Institute, Imperial College London, United Kingdom;Kian Fan Chung##Airways Disease, National Heart & Lung Institute, Imperial College London, United Kingdom;Paolo Montuschi¶¶Dept of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Rome, Italy;Stephen J. Fowler++Lecturer and Honorary Consultant in Respiratory Medicine, University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Respiratory Research Group, Education and Research Centre, Wythenshawe Hospital, Manchester, United Kingdom;Ian M. Adcock##Airways Disease, National Heart & Lung Institute, Imperial College London, United Kingdom;Anthony D. Postle¶Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, Southampton, United Kingdom;Sven-Erik Dahlén#Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden;§§Unit for Experimental Asthma and Allergy Research, Karolinska Institutet, Stockholm, Sweden;Anthony RoweffJanssen Research and Development Ltd, High Wycombe, UKPeter J. Sterk***Dept of Respiratory Medicine, Academic Medical Center University of Amsterdam, Amsterdam, The NetherlandsCharles Auffray**CNRS Institute of Biological Sciences, European Institute for Systems Biology & Medicine, Claude Bernard University, Lyon, France;Ratko Djukanović¶Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, Southampton, United Kingdom;
- Urinary LTE4 may be associated with TH2-driven asthma: Initial data from the Pan-European U-BIOPRED IMI projectBy Marcus Sjödin, Johan Kolmert, David Balgoma, Ingrid Delin, Ratko Djukanovic, Julie Corfield, Fan Chung, Ana Sousa, Chris Compton, David Myles, Anthony Rowe, Peter Sterk, Craig Wheelock and Sven-Erik DahlénMarcus Sjödin1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenJohan Kolmert1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenDavid Balgoma2Dept Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, SwedenIngrid Delin1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenRatko Djukanovic3Medicine, University of Southampton, Southampton, United KingdomJulie Corfield3Medicine, University of Southampton, Southampton, United KingdomFan Chung4Medicine, Imperial College, London, United KingdomAna Sousa5Medical affairs, GSK, London, United KingdomChris Compton6University Relations, Novartis, London, United KingdomDavid Myles5Medical affairs, GSK, London, United KingdomAnthony Rowe7Biostatistics, Johnson & Johnson, London, United KingdomPeter Sterk8Physiology and Medicine, University of Amsterdam, Amsterdam, NetherlandsCraig Wheelock2Dept Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, SwedenSven-Erik Dahlén1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- LATE-BREAKING ABSTRACT: Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPDBy David Balgoma, Mingxing Yang, Marcus Sjodin, Stuart Snowden, Reza Karimi, Bettina Levanen, Heta Merikallio, Riitta Kaarteenaho, Lena Palmberg, Kjell Larsson, David Erle, Sven-Erik Dahlen, Barbro Dahlen, Magnus Skold, Asa Wheelock and Craig WheelockDavid Balgoma1Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, SwedenMingxing Yang2Medicine, Karolinska Institute, Stockholm, SwedenMarcus Sjodin1Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, SwedenStuart Snowden1Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, SwedenReza Karimi2Medicine, Karolinska Institute, Stockholm, SwedenBettina Levanen2Medicine, Karolinska Institute, Stockholm, SwedenHeta Merikallio2Medicine, Karolinska Institute, Stockholm, SwedenRiitta Kaarteenaho3Respiratory Unit, Oulu University, Oulu, FinlandLena Palmberg4Institute of Environmental Medicine, Karolinska Institute, Stockholm, SwedenKjell Larsson4Institute of Environmental Medicine, Karolinska Institute, Stockholm, SwedenDavid Erle5Medicine, University of California San Francisco, San Francisco, United StatesSven-Erik Dahlen4Institute of Environmental Medicine, Karolinska Institute, Stockholm, SwedenBarbro Dahlen6Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, SwedenMagnus Skold2Medicine, Karolinska Institute, Stockholm, SwedenAsa Wheelock2Medicine, Karolinska Institute, Stockholm, SwedenCraig Wheelock1Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
- Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPDBy David Balgoma, Mingxing Yang, Marcus Sjödin, Stuart Snowden, Reza Karimi, Bettina Levänen, Heta Merikallio, Riitta Kaarteenaho, Lena Palmberg, Kjell Larsson, David J. Erle, Sven-Erik Dahlén, Barbro Dahlén, C. Magnus Sköld, Åsa M. Wheelock and Craig E. WheelockArticle | Published in 2016 in European Respiratory JournalDavid Balgoma1Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden2Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenMingxing Yang3Respiratory Medicine Unit, Dept of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, SwedenMarcus Sjödin1Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, SwedenStuart Snowden1Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, SwedenReza Karimi3Respiratory Medicine Unit, Dept of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, SwedenBettina Levänen3Respiratory Medicine Unit, Dept of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, SwedenHeta Merikallio3Respiratory Medicine Unit, Dept of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden4Respiratory Unit, Medical Research Center Oulu, Oulu University/UniversityHospital, Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland & Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, FinlandRiitta Kaarteenaho4Respiratory Unit, Medical Research Center Oulu, Oulu University/UniversityHospital, Medicine and Clinical Research, Pulmonary Division, University of Eastern Finland & Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, FinlandLena Palmberg5Lung and Airway Research Unit, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenKjell Larsson5Lung and Airway Research Unit, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenDavid J. Erle6Division of Pulmonary and Critical Care, Department of Medicine and Lung Biology Center, University of California San Francisco, San Francisco, USASven-Erik Dahlén2Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenBarbro Dahlén7Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, SwedenC. Magnus Sköld3Respiratory Medicine Unit, Dept of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, SwedenÅsa M. Wheelock3Respiratory Medicine Unit, Dept of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden8Both authors contributed equallyCraig E. Wheelock1Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden8Both authors contributed equally
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
